Organic Active Ingredients TRIZ Cases

Intragranular and extragranular superdisintegrants in a compressed raltegravir tablet increase drug load while reducing weight and pharmacokinetic variability.

Simplified Bryoid analogs replicate therapeutic activity of Bryostatin 1 while reducing synthesis complexity and cost.

Four substituted groups on the piperazine core resolve low affinity and specificity issues in existing drug candidates.

Composite surfactant system with hydrocarbon propellants prevents API degradation during storage while ensuring consistent drug delivery.

rs2237457 genotyping directs TAAR1 agonist use, avoiding antipsychotic treatment resistance and metabolic side effects.

Formula I compounds modulate histone methyl modifying enzyme activity to resolve ineffective modulation of crucial biological processes.

Tellurium compounds stimulate the immune system to target human papillomavirus infections.

Administering SLC26A11 inhibitors reduces chloride ion influx into brain cells to mitigate cellular swelling.

A reconstituted high density lipoprotein formulation reduces detergent concentration to minimize liver toxicity while maintaining therapeutic activity.

A one-pot process synthesizes saturated 6,14-dihydroxy morphinans through sequential oxidation and reduction steps.

Isomerically pure neurosteroids selectively target alpha4beta3delta GABAA receptors through defined stereochemical configurations.

Blocks CXCL8 signaling to overcome anticancer drug resistance and enhance sensitivity in EGFR mutant cancers.

Coated nut and seed products address dietary micronutrient deficiencies by applying a thin film containing vitamins and minerals to the food surface.

Oligosaccharides accelerate insulin absorption by promoting hexamer dissociation into active monomers.

2-Oxo-1,2-dihydropyridine-3,5-dicarboxamide compounds inhibit bromodomain 2 of BET family proteins through specific structural binding.

Inhibiting UCP1 negative regulators promotes thermogenic potential, eliminating complex external stimulation protocols.

Segmented DsiRNAs targeting SAV1, NF2, and MOB1 promote cardiac cell proliferation while managing treatment protocol complexity.

Improved synthetic process for compound of Formula I utilizes adipic acid co-crystallization to achieve high purity without chromatography.

A mannuronic diacid oligosaccharide composition treats Parkinson's disease by optimizing biological activity through specific polymerization degrees.

Akt protein markers identify invasive glioblastoma cells, preventing ineffective standard treatments by enabling precise patient stratification.

Allergin-1 biomarkers identify leukemia stem cells to overcome chemotherapy resistance and improve long-term survival rates.

Pyrazolo-heteroaryl compounds selectively activate TLR7 over TLR8, minimizing TNF-alpha side effects and CYP inhibition.

Acidic buffered fentanyl liquid formulations maintain concentration integrity during terminal sterilization in infusion containers.

A low-molecular-weight compound targets tumor virus gene products to suppress viral replication and inhibit tumor growth.

Lanolin releases cholesterol while squalane enhances cannabinoid penetration to treat dermal wounds.

A zolpidem sublingual tablet formulation uses polacrillin potassium to mask bitter taste while maintaining rapid disintegration.

Detecting RNF43 mutations selects patients responsive to Wnt inhibitors, bypassing resistance from downstream APC or beta-catenin alterations.

UV irradiation and flutamide overcome estrogen tolerance to efficiently produce YY super-male and XY physiological female common carps.

A collagen and sodium hyaluronate hydrogel forms a stable network through physical entanglement and hydrogen bonding.

A lidocaine hydrogel patch uses pH adjustment and oleic acid to stabilize the adhesive layer.

Alkaline buffers adjust renal nerve tissue pH and tonicity, enabling enhanced drug absorption without complex delivery systems.

Quinazoline compounds inhibit TNNI3K kinase activity to disrupt hypertrophic signaling pathways and mitigate pathological cardiac hypertrophy.

Cationic polymer coatings on mesoporous silica nanoparticles reduce reticuloendothelial system sequestration, increasing tumor dose accumulation to 12%.

Guide RNA directs Cas9 to edit the TTR gene, halting disease progression and improving quality of life in ATTR amyloidosis patients.

A 4-isopropylphenyl glucitol compound inhibits SGLT1 to treat constipation via osmotic pressure.

Negatively charged modulated guanidine polymers bypass mucus barriers to deliver siRNA, improving transfection efficiency without cellular toxicity.

A Linifanib prodrug compound binds to a polypeptide via a multi-carbon chain for selective tumor site accumulation.

Combining opioid analgesics with aldehyde dehydrogenase inhibitors creates a fixed-dose medication that prevents alcohol consumption.

Specific dosing regimens for irreversible tyrosine kinase inhibitors and monoclonal antibodies overcome T790M-mediated resistance mechanisms.

A purification process for sodium hyaluronic acid uses controlled precipitation and dissolution cycles to isolate the target compound from fermentation broth.

Novel 3-aryloxyl heteroaryl propylamine compounds inhibit TRPA1 channels to provide analgesic activity.

Fusing a nicotine bitartrate portion onto a polacrilex core resolves the contradiction between immediate craving relief and extended duration.

Heterocyclic compounds selectively activate sphingosine 1 phosphate receptor subtype 1, minimizing harmful side effects from subtype 3 activation.

Fluorinated macrocyclic structures enhance CDK9 selectivity and potency at high ATP concentrations while reducing toxicity.

Deoxycholic acid formulations treat Streptococcus pneumoniae via local delivery, reducing systemic toxicity and antibiotic resistance risks.